Merck & Co Unusual Options Activity
Merck & Co Unusual Options Activity
Financial giants have made a conspicuous bearish move on Merck & Co. Our analysis of options history for Merck & Co (NYSE:MRK) revealed 8 unusual trades.
金融巨頭對默沙東採取了明顯的看淡策略。我們對默沙東（NYSE：MRK）期權歷史進行分析，發現出現了8次飛凡交易。
Delving into the details, we found 12% of traders were bullish, while 75% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $78,155, and 6 were calls, valued at $318,290.
具體來說，我們發現12%的交易者看漲，而75%顯示出看淡的趨勢。我們發現的所有交易中，有2個看跌期權，價值78155美元，有6個看漲期權，價值318290美元。
What's The Price Target?
價格目標是什麼？
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $90.0 and $130.0 for Merck & Co, spanning the last three months.
在評估成交量和持倉量後，很明顯，主要市場動向關注默沙東的價格區間在90.0美元至130.0美元之間，該區間持續時間爲三個月。
Volume & Open Interest Trends
成交量和未平倉量趨勢
In today's trading context, the average open interest for options of Merck & Co stands at 1271.25, with a total volume reaching 107.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Merck & Co, situated within the strike price corridor from $90.0 to $130.0, throughout the last 30 days.
在今天的交易環境中，默沙東期權的平均持倉量爲1271.25，總成交量爲107.00。附帶的圖表描述了默沙東高價值交易的看漲期權和看跌期權成交量和持倉量的進展情況，這些交易位於以90.0至130.0美元爲中心的行權價格廊道內，持續了30天。
Merck & Co 30-Day Option Volume & Interest Snapshot
默沙東30天期權成交量及持倉量快照
Noteworthy Options Activity:
值得注意的期權活動：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRK | CALL | TRADE | BEARISH | 01/16/26 | $25.75 | $25.4 | $25.4 | $110.00 | $73.6K | 1.4K | 1 |
| MRK | CALL | TRADE | BEARISH | 01/16/26 | $25.75 | $25.4 | $25.4 | $110.00 | $71.1K | 1.4K | 1 |
| MRK | CALL | TRADE | BEARISH | 01/16/26 | $25.65 | $25.45 | $25.45 | $110.00 | $61.0K | 1.4K | 58 |
| MRK | PUT | SWEEP | BEARISH | 08/16/24 | $5.0 | $4.9 | $5.0 | $130.00 | $46.0K | 1.0K | 41 |
| MRK | CALL | TRADE | BEARISH | 01/16/26 | $25.65 | $25.45 | $25.45 | $110.00 | $45.8K | 1.4K | 58 |
| 標的 | 看跌/看漲 | 交易類型 | 情緒 | 到期日 | 賣盤 | 買盤 | 價格 | 執行價格 | 總交易價格 | 未平倉合約數量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRK | 看漲 | 交易 | 看淡 | 01/16/26 | $25.75 | 25.4美元 | 25.4美元 | $110.00 | 73.6K | 1.4千 | 1 |
| MRK | 看漲 | 交易 | 看淡 | 01/16/26 | $25.75 | 25.4美元 | 25.4美元 | $110.00 | $71.1K | 1.4千 | 1 |
| MRK | 看漲 | 交易 | 看淡 | 01/16/26 | $25.65 | 25.45美元 | 25.45美元 | $110.00 | $61.0K | 1.4千 | 58 |
| MRK | 看跌 | SWEEP | 看淡 | 08/16/24 | $5.0 | $4.9 | $5.0 | $130.00 | $46.0K | 1.0K | 41 |
| MRK | 看漲 | 交易 | 看淡 | 01/16/26 | $25.65 | 25.45美元 | 25.45美元 | $110.00 | $45.8K | 1.4千 | 58 |
About Merck & Co
關於默沙東
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
默沙東生產多種藥品，治療多種領域的疾病，包括心代謝症、癌症和感染。在癌症領域，該公司的免疫腫瘤學平台正在成爲總銷售額的主要貢獻者。該公司還具有實質性的疫苗業務，包括預防兒童疾病以及人類乳頭瘤病毒（HPV）治療。此外，默沙東出售與動物健康相關的藥品。從地理角度來看，公司銷售額的近一半來自於美國境內。
After a thorough review of the options trading surrounding Merck & Co, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
在對默沙東進行全面審查其期權交易後，我們進行更詳細的公司評估。這包括對其當前市場狀態和表現的評估。
Where Is Merck & Co Standing Right Now?
默克與有限公司當前的處境如何？
- With a trading volume of 2,717,064, the price of MRK is down by -0.68%, reaching $125.0.
- Current RSI values indicate that the stock is may be approaching oversold.
- Next earnings report is scheduled for 25 days from now.
- 在2717064的交易量下，MRK的價格下跌0.68%，達到125.0美元。
- 當前RSI值表明該股票可能即將超賣。
- 下一份業績將在25天后發佈。
Professional Analyst Ratings for Merck & Co
默沙東的專業分析師評級
Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $155.0.
在過去的一個月中，有2位行業分析師分享了他們對該股票的看法，提出了平均目標價爲155.0美元。
- An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $155.
- In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Overweight, setting a price target of $155.
- 來自康泰納仕的分析師已經將其評級下調爲超額，將目標價調整爲$155。
- 一個來自Cantor Fitzgerald的分析師採取謹慎舉措，將其評級從“增持”降級爲“超配”，設置了155美元的目標價。
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
期權與僅交易股票相比是一種更具風險的資產，但它們具有更高的利潤潛力。認真的期權交易者通過每日學習，進出交易，跟隨多個指標並密切關注市場來管理這種風險。
譯文內容由第三人軟體翻譯。